EXCLUSIVE OPTION AGREEMENTExclusive Option Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 10th, 2013 Company Industry JurisdictionThis Exclusive Option Agreement (“Agreement”) is entered into this 5th day of December, 2013 (“Effective Date”) by and among Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”), with offices at 8700 Beverly Boulevard, Los Angeles, CA 90048, Synthetic Biologics, Inc., a Nevada corporation (hereinafter, “Synthetic”), with offices at 617 Detroit Street, Suite 100, Ann Arbor, MI 48104 and Synthetic Biomics, Inc., a Nevada corporation (hereinafter, “Company”), having offices at 617 Detroit Street, Suite 100, Ann Arbor, MI 48104 and a wholly-owned subsidiary of Synthetic (each, a “Party,” and together, the “Parties”).
EXCLUSIVE LICENSE AGREEMENTExclusive License Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 10th, 2013 Company Industry JurisdictionTHIS EXCLUSIVE LICENSE AGREEMENT (“Agreement”) is entered into as of this 5th day of December, 2013 (“Effective Date”) by and among CEDARS-SINAI MEDICAL CENTER, a California nonprofit public benefit corporation (“CSMC”), with offices at 8700 Beverly Boulevard, Los Angeles, California 90048-1865, SYNTHETIC BIOLOGICS, INC., a Nevada corporation, with offices at 155 Gibbs Street, Suite 412, Rockville, Maryland 20850 (“Synthetic”), and SYNTHETIC BIOMICS, INC., a Nevada corporation with offices at 155 Gibbs Street, Suite 412, Rockville, Maryland 2085 which is a majority-owned subsidiary of Synthetic (the “Licensee”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 10th, 2013 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is made and entered into as of December 3, 2013 (the “Effective Date”), by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), Synthetic Biomics, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Synbiomics”), and Mark Pimentel, M.D., an individual (“Pimentel”).
STOCK PURCHASE AGREEMENT by and among SYNTHETIC BIOLOGICS, INC., SYNTHETIC BIOMICS, INC. and CEDARS-SINAI MEDICAL CENTER, INC. December 5, 2013Stock Purchase Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 10th, 2013 Company Industry JurisdictionTHIS AGREEMENT (“Agreement”) is made and entered into as of December 5, 2013 (the “Effective Date”), by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), Synthetic Biomics, Inc., a Nevada corporation and wholly owned subsidiary of the Company (“Licensee”) and Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”).
STOCK PURCHASE AGREEMENTStock Purchase Agreement • December 10th, 2013 • Synthetic Biologics, Inc. • Pharmaceutical preparations • California
Contract Type FiledDecember 10th, 2013 Company Industry JurisdictionTHIS AGREEMENT (this “Agreement”) is made and entered into as of December 5, 2013 (the “Effective Date”), by and among Synthetic Biologics, Inc., a Nevada corporation (the “Company”), Synthetic Biomics, Inc., a Nevada corporation and wholly-owned subsidiary of the Company (“Synbiomics”), and Cedars-Sinai Medical Center, a California nonprofit public benefit corporation (“CSMC”).